REG - Inspiration Health - $4.3 million contract

Inspiration HealthcareAnnouncement

25/07/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240725:nRSY7327Xa&default-theme=true

RNS Number : 7327X  Inspiration Healthcare Group PLC  25 July 2024

 

The information contained within this announcement is deemed by the Company to
constitute inside information stipulated under the Market Abuse Regulation
(EU) No. 596/2014 as amended by the Market Abuse (Amendment) (EU Exit)
Regulations 2019. Upon the publication of this announcement via the Regulatory
Information Service, this inside information is now considered to be in the
public domain.

 

25 July 2024

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

$4.3 million contract for delivery of delayed material export order

Contract terms in place for potential long term trading relationship

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company pioneering best-in-class, specialist neonatal intensive care medical
devices, announces it has signed a $4.3 million contract for the delivery of
SLE6000 neonatal ventilators, First Breath™ Humidification and associated
accessories.

 

The contract was anticipated to be signed and products shipped in the previous
financial year but was delayed while final contract terms were negotiated. The
Company is now working to finalise the agreed letter of credit and expects to
ship the products in the second half of the current financial year.

 

The SLE6000 is Inspiration Healthcare's leading, best-in-class neonatal
ventilator, that facilitates precise, controlled ventilation for critically
ill infants. They are used extensively around the world to provide vital life
support to premature and sick babies.

 

Roy Davis, Executive Chair and Interim CEO of Inspiration Healthcare, said:
"This is the largest single order we have executed for our SLE6000 ventilators
and was previously delayed so that we could agree commercial terms and ensure
the foundations for a long-term relationship were in place. We are confident
of swifter and more streamlined negotiations on future potential orders.

 

This significant contract underlines the SLE6000's position as a global
best-in-class neonatal ventilator, which is specifically designed to address a
critical need to help save the lives and improve the outcomes of preterm
babies. We are delighted our products will reach more patients globally,
providing healthcare professionals the ability to support patients, starting
with the very first breaths of life."

 

For further information, please contact:

 

 Inspiration Healthcare Group plc                                                                      Tel: +44 (0)330
                                                                       175 0000
 Roy Davis, Executive Chair and Interim Chief Executive Officer

 Alan Olby, Chief Financial Officer

 Panmure Liberum Capital Limited (Nominated Adviser & Broker)                                          Tel: +44 (0)20
                                                                       3100 2000
 Richard Lindley

 Will King

 Walbrook PR Ltd (Media & IR)       Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
 Anna Dunphy                                                           Mob: +44 (0) 7876 741 001
 Stephanie Cuthbert                                                    Mob: +44 (0) 7796 794 663
 Louis Ashe-Jepson                                                     Mob: +44 (0) 7747 515 393

 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering
medical technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical need to help
to save the lives and improve the outcomes of patients, starting with the very
first breaths of life.

 

The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.

 

The Company sells its products directly to hospitals and healthcare providers
in the UK and Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy.  In the rest of the world the Company has
an established network of distribution partners around the world giving access
to more than 75 countries.

 

The Company operates in the UK from its world-class Manufacturing and
Technology Centre in Croydon, South London and from its facility in Hailsham,
East Sussex, and in the USA from its facility in Melbourne, Florida.

 

Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com (http://www.inspirationhealthcaregroup.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CNTEAXXLAANLEFA